Greenland Mines Prices $20M Public Offering at $5.00/Share to Fund Sarfartoq Acquisition
GRML sits 19% above its 52-week low of $4.37 on elevated volume (6.4× avg).
Summary
Greenland Mines priced a $20 million public offering at $5.00 per share, with net proceeds of ~$18.5 million to fund the Sarfartoq rare earth project acquisition and working capital.
Key Events · Financing and Capital Events · GRML
-
Offering Priced at $5.00/Share
Greenland Mines priced a registered public offering of 1,632,783 shares plus pre-funded warrants for 2,367,517 shares at $5.00 per share (or $4.9999 per warrant), for aggregate gross proceeds of approximately $20 million.
-
Net Proceeds of ~$18.5M
After placement agent fees (7.0% of gross proceeds) and offering expenses, net proceeds are expected to be approximately $18.5 million.
-
Use of Proceeds: Sarfartoq Acquisition
Proceeds will fund the acquisition of the Sarfartoq Nd-Pr Rare Earth Element Project and provide working capital.
-
Closing Expected August 27, 2026
The offering is expected to close on or about August 27, 2026, subject to customary closing conditions.
Analysis · GRML · Life Sciences
Greenland Mines has priced a registered public offering of 4 million shares (or equivalents) at $5.00 per share, raising approximately $18.5 million in net proceeds. The capital is earmarked for the Sarfartoq Nd-Pr rare earth project acquisition and working capital. This is a substantial capital raise for a company with a market cap of roughly $16.7 million and a going-concern warning from its most recent 10-Q. The offering provides critical runway to close the Sarfartoq acquisition, but it is highly dilutive to existing shareholders — the 4 million shares represent a significant expansion of the share count. The pricing at $5.00 is close to the current market price of $5.20, suggesting the deal was priced near market rather than at a deep discount, which is a modest positive signal for institutional demand.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.2% of the 984 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.83%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $5.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.7M. The 52-week trading range was $4.37 to $38.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.